PepsRadar
⌕ Search✧ Ask
Content updated · how dates work
Narrated explainers from PepsRadar, written from the same studies and regulatory records as the rest of the site. Each one links back to its sources.
3:09Video overview · 3:09
What each peptide is, what the short human studies measured, why no published trial has tested the pair together, the serious adverse events FDA has noted, and their FDA and anti-doping status.
Narrated with an AI voice from the linked page's sources; education only, no dosing. Read the full page → · Watch on YouTube ↗
3:24Video overview · 3:24
How epitalon differs from the pineal extract epithalamin, the cell studies behind the telomere claim, the mixed animal lifespan results, why no published study has measured telomeres or lifespan in people given it, and its FDA, compounding and anti-doping status.
Narrated with an AI voice from the linked page's sources; education only, no dosing. Read the full page → · Watch on YouTube ↗
3:18Video overview · 3:18
What the copper peptide is, what the cell and animal studies found, the one small randomized human trial (no objective benefit), why a skin cream and an injection are different questions, and its FDA and anti-doping status.
Narrated with an AI voice from the linked page's sources; education only, no dosing. Read the full page → · Watch on YouTube ↗
3:20Video overview · 3:20
Why MK-677 is not actually a peptide, the trials showing it raises growth hormone and lean mass, why that did not translate into strength or function, the blood-sugar and heart-failure signals, and its FDA and anti-doping status.
Narrated with an AI voice from the linked page's sources; education only, no dosing. Read the full page → · Watch on YouTube ↗
2:44Video overview · 2:44
Where the mitochondrial peptide comes from, how it acts on the cell's energy sensor, the mouse studies behind the hype, why no published study has given it to people, and its FDA, compounding and anti-doping status.
Narrated with an AI voice from the linked page's sources; education only, no dosing. Read the full page → · Watch on YouTube ↗
3:01Video overview · 3:01
What NAD+ is, the trials showing NR and NMN raise it, why benefits for metabolism, muscle and aging have been mixed or null, the thin evidence for IV drips, and its regulatory status.
Narrated with an AI voice from the linked page's sources; education only, no dosing. Read the full page → · Watch on YouTube ↗
2:47Video overview · 2:47
What each peptide is, the rat brain studies behind the memory claim, the small Russian stroke and anxiety studies, why no placebo-controlled trial has tested memory or focus in healthy people, and their FDA and anti-doping status.
Narrated with an AI voice from the linked page's sources; education only, no dosing. Read the full page → · Watch on YouTube ↗
3:35Video overview · 3:35
Where thymosin alpha-1 is approved, why immune markers are not the same as fewer infections, what the large sepsis and pancreatitis trials found, the hepatitis and COVID-19 evidence, and its FDA and anti-doping status.
Narrated with an AI voice from the linked page's sources; education only, no dosing. Read the full page → · Watch on YouTube ↗
2:47Video overview · 2:47
Where it comes from, how it might work, what the rat and cell studies found, how little human data exists, the one registered human trial, and its safety and legal status.
Narrated with an AI voice from the linked page's sources; education only, no dosing. Read the full page → · Watch on YouTube ↗
3:30Video overview · 3:30
How TB-500 differs from the natural protein thymosin beta-4, what the rat and cell studies found, why the only human trials tested the full protein, and its safety, FDA and anti-doping status.
Narrated with an AI voice from the linked page's sources; education only, no dosing. Read the full page → · Watch on YouTube ↗
2:45Video overview · 2:45
How the amylin fullness hormone works, what the 48-week phase 2 trial found, the side effects, how it differs from cagrilintide, the phase 3 trials under way, and why it is not approved.
Narrated with an AI voice from the linked page's sources; education only, no dosing. Read the full page → · Watch on YouTube ↗
3:02Video overview · 3:02
How it copies the gut hormone GLP-1, what the STEP, SELECT and FLOW trials found for weight, heart and kidney outcomes, the side effects and label warnings, the trials still under way, and its FDA approvals.
Narrated with an AI voice from the linked page's sources; education only, no dosing. Read the full page → · Watch on YouTube ↗
3:05Video overview · 3:05
How it acts on two gut-hormone targets, what the SURMOUNT and SURPASS trials found (including a head-to-head trial against semaglutide), the side effects and label warnings, the outcome trials still under way, and its FDA approvals.
Narrated with an AI voice from the linked page's sources; education only, no dosing. Read the full page → · Watch on YouTube ↗
2:49Video overview · 2:49
How the triple-hormone drug is thought to work, what the phase 2 and phase 3 trials found, the side effects, the trials still under way, its legal status, and why vials sold online are not the drug tested in those trials.
Narrated with an AI voice from the linked page's sources; education only, no dosing. Read the full page → · Watch on YouTube ↗
3:08Video overview · 3:08
What the FDA compounding categories mean, why BPC-157 and other peptides left the Category 2 list in April 2026, what the July 2026 advisory committee voted, and why none of that is an approval.
Narrated with an AI voice from the linked page's sources; education only, no dosing. Read the full page → · Watch on YouTube ↗
2:31Video overview · 2:31
What identity, purity and net-content results mean, why purity is not quantity, what a lab lookup does and doesn't confirm, and what PepsRadar found when it opened 61 reports from 10 online shops.
Narrated with an AI voice from the linked page's sources; education only, no dosing. Read the full page → · Watch on YouTube ↗
Under a minute each, one claim at a time. A new one goes up most days.
BPC-157 Left the FDA's Category 2 List. That's Not an Approval
MK-677 for Muscle? A Two-Year Trial Found No Strength Gain
Thymosin Alpha-1: Does It Prevent Infections? The Big Trials Say No
Epitalon and Telomeres: Where the Anti-Aging Claim Comes From
Retatrutide "Research" Vials Aren't the Trial Drug
CJC-1295 + Ipamorelin: Has the Combo Ever Been Tested?
Selank for Anxiety? The Studies Had No Placebo Group
Eloralintide: Lilly's Weight-Loss Drug That Isn't a GLP-1
BPC-157 + TB-500: Has Anyone Tested the Combo?
NAD+ IV Drips: How Many Outcome Trials Back Them?
Stop Tirzepatide and Does the Weight Stay Off? What SURMOUNT-4 Found
Copper Peptide GHK-Cu: What Happened When It Was Tested in People
We Checked 61 Peptide Lab Reports Against the Labs' Own Records
TB-500 Isn't Thymosin Beta-4. Here's the Difference
Ozempic vs Wegovy: Are They Different Drugs?
BPC-157 for Tendons? What the Evidence Actually Is
MOTS-c: "Exercise in a Pill"? Here's the Catch
Semax for Focus? Where the Memory Claim Really Comes From
"99% Pure" Doesn't Mean What You Think: Reading a Peptide Lab ReportNarration and background footage are AI-generated. For research and education only; no video describes doses or how to use a substance.
See something wrong on this page? Report a mistake · Corrections